Since 2013, Abbott has continued to improve the profitability of its four segments: nutritionals, devices, diagnostics, and established pharmaceuticals. Although the company has made progress over ...
US aid freeze sows disruption in HIV, malaria product supply chains The U.S. government's foreign aid freeze has upended the supply chain for medical products crucial for fighting diseases ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback